Product Information

NORELGESTROM-EE 150-35 MCG/DAY is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $31.5441 per EA under NDC 70710119003. Its NADAC has been published 136 times since Apr 17, 2024.

FDA first approved this application on Sep 14, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NORELGESTROM-EE 150-35 MCG/DAY

norelgestromin and ethinyl estradiol
$31.5441per EA

Strength

35; 150 ug/mg; ug/mg

NDC

70710119003

Classification

Generic

Dosage Form

PATCH

Route

TRANSDERMAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA214594

FDA Approved

9/14/2023

TE Code

AB

On Market Since

11/21/2023

Pharmacological Classes

Estrogen Receptor Agonists
Estrogen
Progesterone Congeners
Progestin

Price Statistics

The NADAC for NORELGESTROM-EE 150-35 MCG/DAY has been published 136 times since Apr 17, 2024, and over the history we have for it it has risen 29.3%. The table below summarizes its recorded NADAC range and movement.

Current price$31.5441 per EA
All-time high$38.0867 (Dec 11, 2024)
All-time low$24.0790 (Jul 17, 2024)
52-week high$36.7300
52-week low$31.3170
Median price$36.4689
Average price$35.0218
Largest weekly change+51.2% (Jun 19, 2024)
Weeks tracked136
Tracking sinceApr 17, 2024

Price History

1W

+0.7%

1M

-5.2%

3M

-6.2%

6M

-11.9%

1Y

-14.1%

3Y

N/A

5Y

N/A

All

+29.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of NORELGESTROM-EE 150-35 MCG/DAY?

The current National Average Drug Acquisition Cost (NADAC) for NORELGESTROM-EE 150-35 MCG/DAY, manufactured by Zydus Pharmaceuticals (USA) Inc., is $31.5441 per EA (NDC 70710119003), effective Nov 18, 2026.

How has the price of NORELGESTROM-EE 150-35 MCG/DAY changed over time?

Over the history we have for it, the NADAC for NORELGESTROM-EE 150-35 MCG/DAY has risen 29.3%. It has been tracked across 136 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for NORELGESTROM-EE 150-35 MCG/DAY?

Since Apr 17, 2024, the NADAC for NORELGESTROM-EE 150-35 MCG/DAY has ranged from a low of $24.0790 (Jul 17, 2024) to a high of $38.0867 (Dec 11, 2024), with a median of $36.4689 per EA.

Are there cheaper alternatives to NORELGESTROM-EE 150-35 MCG/DAY?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NORELGESTROM-EE 150-35 MCG/DAY in a comparable dosage form, but none are currently priced below it.

Who manufactures NORELGESTROM-EE 150-35 MCG/DAY?

NORELGESTROM-EE 150-35 MCG/DAY (NDC 70710119003) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.